Success Metrics

Active Trials
3(100%)

Phase Distribution

Ph early_phase_1
1
33%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
Early Phase 1First-in-human
1(100.0%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

3

all time

Status Distribution
Active(3)

Detailed Status

Recruiting2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
3
Success Rate
N/A
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (100.0%)

Trials by Status

active_not_recruiting133%
recruiting267%

Recent Activity

3 active trials
Showing 3 of 3
recruitingearly_phase_1

SV2A Density Cannabis Use Disorder

NCT05472818
recruiting

SV2 PET Imaging With [11C]APP311

NCT03995121
active_not_recruiting

Imaging mGluR5 and Synaptic Density in Psychiatric Disorders

NCT03898297

Clinical Trials (3)

Showing 3 of 3 trials
NCT05472818Early Phase 1

SV2A Density Cannabis Use Disorder

Recruiting
NCT03995121

SV2 PET Imaging With [11C]APP311

Recruiting
NCT03898297

Imaging mGluR5 and Synaptic Density in Psychiatric Disorders

Active Not Recruiting

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3